OncoDEEP Kit is an integrated solution that combines a pan-cancer NGS assay and bioinformatics tools for the in-house comprehensive biomarker testing of tumor tissues. The OncoDEEP Kit panel targets DNA and RNA across over 600 genes, assessing biomarkers associated with the latest cancer drugs and clinical trials available for solid tumors. It also measures complex genomic signatures, such as homologous recombination deficiency (HRD), microsatellite instability (MSI), tumor mutational burden (TMB), and loss of heterozygosity (LOH).
OncoDEEP Kit provides a complete solution for laboratories willing to enhance their NGS efforts and to adopt comprehensive biomarker testing in house. With this offering, even laboratories with limited bioinformatics capabilities have the combined ability to profile a large number of cancer biomarkers and assess complex biomarkers in a single test. Combined with OncoDNA bioinformatics software tools, OncoDEEP Kit will enable you to identify a broader set of treatment options for patients, while saving on time and cost of outsourcing.
We see biomarkers such as HRD and MSI play an increasingly essential role in precision medicine, however, the development and validation of the pan-cancer bioanalytical methods remain burdensome. With its OncoDEEP kit, OncoDNA provides us with the appropriate tools to analyze such complex biomarkers. I feel confident that it will help us access critical insights to drive precision medicine.
Molecular Biologist, AZ Sint-Lucas Gent
OncoDEEP Kit includes all the materials required to perform the comprehensive biomarker testing of solid tumors. The Kit comes with the reagents and probes associated with Twist Capture technology, as well as with the bioinformatics pipeline and our secure, cloud-based MERCURY software to analyze the raw data and access extensive quality control tools. OncoDNA also offers the opportunity to run the sequencing data through its proprietary database and extract patient-specific clinical interpretation reports made available on its OncoKDM online platform. To date, its database counts no less than 4,500,000 genetic variants, 1,150 cancer drugs, and data from 7,000 clinical trials.
Laboratories will have the opportunity to select two types of OncoDEEP Kit: one kit for DNA sequencing only, and another one for the combination of DNA and RNA sequencing.
Cannot find what you are looking for? Contact us! Our Scientific Support Teams are available to answer all your questions from Monday to Friday.